Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)

NCT: NCT04192591 · ACTIVE_NOT_RECRUITING

NCT IDNCT04192591
StatusACTIVE_NOT_RECRUITING
Start Date2020-01-30
Completion2041-02

Brief Summary

To compile real-world outcomes of the Superion™ IDS in routine clinical practice.

Frequently Asked Questions

What is A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)?

A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE) is a clinical trial registered under NCT04192591. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04192591?

The current status of NCT04192591 (A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)) is: ACTIVE_NOT_RECRUITING.

When did A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE) start?

A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE) started on 2020-01-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑